Roy Andrew Morgan
Direktor/Vorstandsmitglied bei Stemina Biomarker Discovery, Inc.
Profil
Roy Andrew Morgan is currently the Director at Stemina Biomarker Discovery, Inc., as well as the EVP-Regulatory Affairs & Quality Operations at both Zurex Pharma, Inc. and Zurex PharmAgra LLC.
Previously, he held positions as Director-Regulatory Affairs at Celltech Pharmaceuticals, Inc., VP-Regulatory, Quality & Pharmaceutical Sciences at Bone Care International, Inc., Vice President-Quality Operations at Genzyme Corp., and Manager-Regulatory Affairs & Labeling at Medeva Pharmaceuticals, Inc. Morgan received his undergraduate degree from Southwestern Oklahoma State University.
Aktive Positionen von Roy Andrew Morgan
Unternehmen | Position | Beginn |
---|---|---|
Stemina Biomarker Discovery, Inc.
Stemina Biomarker Discovery, Inc. BiotechnologyHealth Technology Stemina Biomarker Discovery, Inc. engages in the development and commercialization of molecular biomarkers to improve drug safety and human health. Its products and services include Cardio quickPredict, devTOX quickPredict, and TOXquickPredict. The company was founded by Elizabeth L. R. Donley and Gabriela G. Cezar in November 2006 and is headquartered in Madison, WI. | Direktor/Vorstandsmitglied | - |
Zurex Pharma, Inc.
Zurex Pharma, Inc. Medical SpecialtiesHealth Technology Zurex Pharma, Inc. provides safe and effective anti-microbial products. Its products include ZuraPrep, a pre-surgical skin preparation for the prevention of SSI; ZurAsept, an antimicrobial and antithrombotic catheter solution to reduce CRBSI; and ZuraGard that prevents extra-luminal or exit site wound CRBSI. The company was founded in April 2008 and is headquartered in Middleton, WI. | General Counsel | - |
Zurex PharmAgra LLC | General Counsel | - |
Ehemalige bekannte Positionen von Roy Andrew Morgan
Unternehmen | Position | Ende |
---|---|---|
Bone Care International, Inc.
Bone Care International, Inc. Pharmaceuticals: OtherHealth Technology Bone Care International, Inc. developed innovative therapeutic products. Its products included Hectorol Injections and Capsules. The company was located in Middleton, WI. | General Counsel | - |
Medeva Pharmaceuticals, Inc.
Medeva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of UCB SA, Medeva Pharmaceuticals, Inc. is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Rochester, NY. Medeva Pharmaceuticals was founded in 1998. | General Counsel | - |
Celltech Pharmaceuticals, Inc. | General Counsel | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Ausbildung von Roy Andrew Morgan
Southwestern Oklahoma State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 7 |
---|---|
Bone Care International, Inc.
Bone Care International, Inc. Pharmaceuticals: OtherHealth Technology Bone Care International, Inc. developed innovative therapeutic products. Its products included Hectorol Injections and Capsules. The company was located in Middleton, WI. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Stemina Biomarker Discovery, Inc.
Stemina Biomarker Discovery, Inc. BiotechnologyHealth Technology Stemina Biomarker Discovery, Inc. engages in the development and commercialization of molecular biomarkers to improve drug safety and human health. Its products and services include Cardio quickPredict, devTOX quickPredict, and TOXquickPredict. The company was founded by Elizabeth L. R. Donley and Gabriela G. Cezar in November 2006 and is headquartered in Madison, WI. | Health Technology |
Medeva Pharmaceuticals, Inc.
Medeva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of UCB SA, Medeva Pharmaceuticals, Inc. is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Rochester, NY. Medeva Pharmaceuticals was founded in 1998. | Health Technology |
Zurex Pharma, Inc.
Zurex Pharma, Inc. Medical SpecialtiesHealth Technology Zurex Pharma, Inc. provides safe and effective anti-microbial products. Its products include ZuraPrep, a pre-surgical skin preparation for the prevention of SSI; ZurAsept, an antimicrobial and antithrombotic catheter solution to reduce CRBSI; and ZuraGard that prevents extra-luminal or exit site wound CRBSI. The company was founded in April 2008 and is headquartered in Middleton, WI. | Health Technology |
Zurex PharmAgra LLC | |
Celltech Pharmaceuticals, Inc. |